About the Journal

About the Journal

Biomedical and Pharmacological Literature Archives (BPLA) e-ISSN : 3117-7328  is an international, peer-reviewed, open-access journal dedicated to publishing high-quality research across the full spectrum of biomedical sciences, pharmacology, and therapeutic innovation. The journal serves as a comprehensive academic archive for cutting-edge scientific literature that advances understanding of human health, disease mechanisms, drug development, and biomedical technologies.

Published by The Scientific Institute of Stanford & Oxbridge Rowan Group (TSI–SORG). , BPLA provides a global platform for researchers, clinicians, pharmacologists, biomedical scientists, and healthcare professionals to disseminate original research, critical reviews, case studies, and translational findings that contribute to improving health outcomes.

Aims and Scope

The journal welcomes submissions in, but not limited to, the following areas:

Biomedical Sciences

  • Molecular biology, cell biology, and genetics

  • Immunology and infectious diseases

  • Physiology, pathology, and clinical diagnostics

  • Neuroscience, cognitive biology, and neuropharmacology

  • Biomedical engineering and medical devices

  • Regenerative medicine and stem cell research

  • Clinical and translational biomedical research

Pharmacological Sciences

  • Pharmacodynamics and pharmacokinetics

  • Drug discovery and development

  • Toxicology and experimental therapeutics

  • Natural product pharmacology

  • Clinical trials and evidence-based medicine

  • Pharmaceutical biotechnology and formulations

  • Personalized and precision medicine

BPLA encourages interdisciplinary studies that bridge biomedical research with pharmacological advancements to provide a holistic understanding of therapeutic science.

Mission

The mission of Biomedical and Pharmacological Literature Archives is to:

  • Promote scientific excellence in biomedical and pharmacological research

  • Support innovative, ethical, and clinically relevant scientific inquiry

  • Provide a global open-access platform for knowledge dissemination

  • Strengthen the bridge between laboratory discoveries and patient care

  • Serve as a long-term scholarly archive of essential biomedical literature

Peer Review and Editorial Process

All submissions undergo a rigorous double-blind peer review conducted by experts in the relevant fields.
Manuscripts are evaluated for:

  • Scientific merit

  • Methodological rigor

  • Novelty and contribution to the field

  • Clarity and ethical compliance

The journal follows the best practices established by COPE, ICMJE, and international publishing standards.

Open Access Policy

BPLA follows a Gold Open Access model, making all published content freely accessible without subscription barriers. Articles are published under the Creative Commons Attribution (CC BY 4.0) license, enabling unrestricted reuse with proper citation.

Digital Preservation and Indexing

To ensure long-term accessibility and integrity, all published content is preserved through:

  • PKP Preservation Network (PKP PN)

  • LOCKSS / CLOCKSS

  • Crossref DOI registration

The journal aligns with the standards required for indexing in Scopus, Web of Science, and DOAJ.

Target Audience

The journal caters to:

  • Biomedical scientists

  • Pharmacologists

  • Clinicians and healthcare researchers

  • Pharmaceutical developers

  • Academics, educators, and medical students

  • Biotechnology and life-science professionals